rapamycin-eluting stent

DEVICE3 trials

Sponsors

Deutsches Herzzentrum Muenchen

Conditions

Coronary DiseaseCoronary Heart Disease

Phase 4

Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

CompletedNCT00140530

Deutsches Herzzentrum MuenchenCoronary Disease

Start: 2004-03-31End: 2005-06-30Updated: 2008-01-11

The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis

CompletedNCT00332397

Deutsches Herzzentrum MuenchenCoronary Disease

Start: 2006-03-31End: 2007-07-31Updated: 2008-06-17

Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)

CompletedNCT00402636

Deutsches Herzzentrum MuenchenCoronary Heart Disease

Start: 2005-03-31End: 2006-10-31Updated: 2007-11-28

Related Papers

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

2010-04-2280 citations

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.

2009-02-2492 citations